|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.50 AUD | +2.14% |
|
+2.34% | -15.73% |
| 07-01 | Clinuvel Pharmaceuticals Extends CEO Philippe Wolgen's Term of Employment | MT |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 360M | |||||
| 68.8B | |||||
| 55.21B | |||||
| 43.46B | |||||
| 41.18B | - | ||||
| 31.65B | - |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
